Trial Profile
Phase II, Observer-blind Follow-up Study to Assess reacto-and Immunogenicity of GSK Biologicals' Pneumococcal Conjugate Vaccine (GSK1024850A), When Given as Booster in Primed Children or as 2-dose Catch-up in Unprimed Children.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jun 2023
Price :
$35
*
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Hepatitis A vaccine inactivated; Hib DTaP hepatitis B poliovirus vaccine (Infanrix hexa)
- Indications Otitis media; Pneumococcal infections; Pneumonia
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK
- 04 Oct 2016 New trial record